JP2022530647A5 - - Google Patents
Info
- Publication number
- JP2022530647A5 JP2022530647A5 JP2021564465A JP2021564465A JP2022530647A5 JP 2022530647 A5 JP2022530647 A5 JP 2022530647A5 JP 2021564465 A JP2021564465 A JP 2021564465A JP 2021564465 A JP2021564465 A JP 2021564465A JP 2022530647 A5 JP2022530647 A5 JP 2022530647A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962840945P | 2019-04-30 | 2019-04-30 | |
| US62/840,945 | 2019-04-30 | ||
| PCT/US2020/030817 WO2020223536A1 (en) | 2019-04-30 | 2020-04-30 | Substituted cyclolakyls as modulators of the integrated stress pathway |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022530647A JP2022530647A (ja) | 2022-06-30 |
| JP2022530647A5 true JP2022530647A5 (https=) | 2023-05-12 |
| JPWO2020223536A5 JPWO2020223536A5 (https=) | 2023-05-12 |
Family
ID=71465400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564465A Pending JP2022530647A (ja) | 2019-04-30 | 2020-04-30 | 統合的ストレス経路の置換シクロアルキルモジュレーター |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20210363136A1 (https=) |
| EP (1) | EP3962899A1 (https=) |
| JP (1) | JP2022530647A (https=) |
| KR (1) | KR20220016467A (https=) |
| CN (1) | CN114401952A (https=) |
| AR (1) | AR118836A1 (https=) |
| AU (2) | AU2020266592B2 (https=) |
| BR (1) | BR112021021754A2 (https=) |
| CA (1) | CA3138144A1 (https=) |
| IL (1) | IL287660A (https=) |
| MX (1) | MX2021013193A (https=) |
| SG (1) | SG11202111970WA (https=) |
| TW (1) | TW202106671A (https=) |
| UY (1) | UY38685A (https=) |
| WO (1) | WO2020223536A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3071024A1 (en) | 2017-08-09 | 2019-02-14 | Denali Therapeutics Inc. | Compounds, compositions and methods |
| CN111201245B (zh) | 2017-09-01 | 2024-04-05 | 戴纳立制药公司 | 化合物、组合物和方法 |
| WO2019090088A1 (en) | 2017-11-02 | 2019-05-09 | Calico Life Sciences Llc | Modulators of the integrated stress pathway |
| CN111757739A (zh) | 2017-12-13 | 2020-10-09 | 普拉西斯生物技术有限责任公司 | 整合应激反应路径抑制剂 |
| AU2019282253A1 (en) | 2018-06-05 | 2020-11-26 | Altos Labs, Inc. | Inhibitors of integrated stress response pathway |
| TW202545902A (zh) | 2018-10-11 | 2025-12-01 | 美商嘉來克生命科學有限責任公司 | 整合應激路徑之前藥調節劑 |
| EP3924341A4 (en) | 2019-02-13 | 2022-11-02 | Denali Therapeutics Inc. | Compounds, compositions and methods |
| SG11202108552QA (en) | 2019-02-13 | 2021-09-29 | Denali Therapeutics Inc | Compounds, compositions and methods |
| WO2020252207A1 (en) | 2019-06-12 | 2020-12-17 | Praxis Biotech LLC | Modulators of integrated stress response pathway |
| CN115190813B (zh) | 2020-03-11 | 2024-10-15 | 埃沃特克国际有限责任公司 | 整合应激反应途径的调节剂 |
| EP4232153A1 (en) | 2020-10-22 | 2023-08-30 | Evotec International GmbH | Modulators of the integrated stress response pathway |
| RS66455B1 (sr) | 2020-10-22 | 2025-02-28 | Evotec Int Gmbh | Modulatori puta integrisanog odgovora na stres |
| EP4232447A1 (en) | 2020-10-22 | 2023-08-30 | Evotec International GmbH | Modulators of the integrated stress response pathway |
| IL302440A (en) * | 2020-10-30 | 2023-06-01 | Calico Life Sciences Llc | Combined pressure pathway modulators |
| TWI863059B (zh) * | 2021-12-23 | 2024-11-21 | 李長榮化學工業股份有限公司 | 二胺化合物及其製備方法、二胺化合物形成的高分子及其用途 |
| EP4452952A4 (en) * | 2021-12-25 | 2025-12-03 | Council Of Scient And Industrial Research An Indian Registered Body Incorporated Under Regn Of Soc A | PREPARATION OF QUINAZOLINEDIONES AND THEIR USE |
| CN114839296B (zh) * | 2022-05-13 | 2023-12-22 | 普研（上海）标准技术服务有限公司 | 食品中牛肉酮的检测方法 |
| CN116768877B (zh) * | 2022-05-30 | 2026-03-31 | 中国药科大学 | Isr抑制剂及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI763668B (zh) * | 2016-05-05 | 2022-05-11 | 美商嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| TW201808888A (zh) * | 2016-05-05 | 2018-03-16 | 嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| WO2018225093A1 (en) * | 2017-06-07 | 2018-12-13 | Glaxosmithkline Intellectual Property Development Limited | Chemical compounds as atf4 pathway inhibitors |
| UY37956A (es) * | 2017-11-02 | 2019-05-31 | Abbvie Inc | Moduladores de la vía de estrés integrada |
| UY37958A (es) * | 2017-11-02 | 2019-05-31 | Abbvie Inc | Moduladores de la vía de estrés integrada |
| UY37957A (es) * | 2017-11-02 | 2019-05-31 | Abbvie Inc | Moduladores de la vía de estrés integrada |
| WO2019183589A1 (en) * | 2018-03-23 | 2019-09-26 | Denali Therapeutics Inc. | Modulators of eukaryotic initiation factor 2 |
| PE20220572A1 (es) * | 2019-04-30 | 2022-04-20 | Calico Life Sciences Llc | Moduladores de la via integrada del estres |
-
2020
- 2020-04-30 SG SG11202111970WA patent/SG11202111970WA/en unknown
- 2020-04-30 AR ARP200101239A patent/AR118836A1/es not_active Application Discontinuation
- 2020-04-30 TW TW109114677A patent/TW202106671A/zh unknown
- 2020-04-30 JP JP2021564465A patent/JP2022530647A/ja active Pending
- 2020-04-30 BR BR112021021754A patent/BR112021021754A2/pt not_active Application Discontinuation
- 2020-04-30 WO PCT/US2020/030817 patent/WO2020223536A1/en not_active Ceased
- 2020-04-30 KR KR1020217039167A patent/KR20220016467A/ko not_active Withdrawn
- 2020-04-30 EP EP20736803.6A patent/EP3962899A1/en active Pending
- 2020-04-30 CN CN202080048079.9A patent/CN114401952A/zh active Pending
- 2020-04-30 MX MX2021013193A patent/MX2021013193A/es unknown
- 2020-04-30 AU AU2020266592A patent/AU2020266592B2/en active Active
- 2020-04-30 CA CA3138144A patent/CA3138144A1/en active Pending
- 2020-04-30 US US16/863,737 patent/US20210363136A1/en not_active Abandoned
- 2020-05-04 UY UY0001038685A patent/UY38685A/es not_active Application Discontinuation
-
2021
- 2021-10-28 IL IL287660A patent/IL287660A/en unknown
-
2023
- 2023-09-07 US US18/462,918 patent/US20240018133A1/en active Pending
-
2026
- 2026-01-29 AU AU2026200630A patent/AU2026200630A1/en not_active Withdrawn